A
Angelo Branzi
Researcher at University of Bologna
Publications - 350
Citations - 17546
Angelo Branzi is an academic researcher from University of Bologna. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 58, co-authored 350 publications receiving 16425 citations.
Papers
More filters
Journal ArticleDOI
Sildenafil citrate therapy for pulmonary arterial hypertension.
Nazzareno Galiè,Hossein Ardeschir Ghofrani,Adam Torbicki,Robyn J. Barst,Lewis J. Rubin,David B. Badesch,Thomas R. Fleming,Tamiza Parpia,Gary Burgess,Angelo Branzi,Friedrich Grimminger,Marcin Kurzyna,Gérald Simonneau +12 more
TL;DR: Among the 222 patients completing one year of treatment with sildenafil monotherapy, the improvement from baseline at one year in the distance walked in six minutes was 51 m, and the incidence of clinical worsening did not differ significantly between the patients treated with s Bildenafils and those treated with placebo.
Journal ArticleDOI
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
Patrick W. Serruys,Pim J. de Feyter,Carlos Macaya,Norbert Kokott,Jacques Puel,Matthias Vrolix,Angelo Branzi,M. C. Bertolami,Graham Jackson,Bradley H. Strauss,Bernhard Meier +10 more
TL;DR: Fuvastatin treatment in patients with average cholesterol levels undergoing their first successful PCI significantly reduces the risk of major adverse cardiac events.
Journal ArticleDOI
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
TL;DR: ‘Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes’ recently published in European Heart Journal 1 rightly dedicates space to the pitfalls that can be encountered when reading presentation ECGs, but there is an important omission.
Journal ArticleDOI
Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy
Enrica Perugini,Pier Luigi Guidalotti,Fabrizio Salvi,Robin M. T. Cooke,Cinzia Pettinato,Letizia Riva,Ornella Leone,Mohsen Farsad,Paolo Ciliberti,Letizia Bacchi-Reggiani,Francesco Fallani,Angelo Branzi,Claudio Rapezzi +12 more
TL;DR: It is concluded that 99mTc-DPD scintigraphy is a useful step in the workup of the differential diagnosis of TTR versus AL etiology in patients with documented cardiac amyloidosis.
Journal ArticleDOI
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Nazzareno Galiè,Alessandra Manes,Luca Negro,Massimiliano Palazzini,Maria Letizia Bacchi-Reggiani,Angelo Branzi +5 more
TL;DR: A meta-analysis of all randomized controlled trials with drugs published in this condition suggests an improvement of survival in the patients treated with the targeted therapies approved for pulmonary arterial hypertension.